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Letters to the Editorincluded in the investigation. For example,
in the study of Fakler and associates,1 new
formulas with new coefficients could be
calculated using 70 patients included in
their investigation and could be validated
against the remaining 73 patients for com-
paring measured and estimated VO2.
Fakler and associates1 reported that the
routine use of assumed VO2 when calcu-
lating cardiac output with the direct Fick
principle might frequently result in large
errors in the estimation of cardiac output
and dependent parameters. To obtain reli-
able cardiac output values by the direct
Fick equation, VO2 should be measured as
concluded by Fakler and associates1 or es-
timated with a new formula calculated us-
ing the population included in the study.
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Reply to the Editor:
We thank Benallal for his comments on our
article and appreciate his remarks.
Our study was specifically designed to
assess the importance of measured oxygen
consumption (VO2) in the preoperative diag-
nostic hemodynamic evaluation during car-
diac catheterization and to assess whether
published formulas allow a reliable calcula-
tion of VO2. We did not intend to develop a
new formula to assume VO2.
Our results emphasize that both the
Krovetz-Goldbloom formula,1 which had
been used to this point in our institution,
and the more commonly used formula pub-
lished by LaFarge and Miettinen2 are not
Tfeasible in all patients to assume VO2 and
thereby calculate cardiac output by the Fick
principle.
Li and colleagues3 presented the impor-
tant conclusion that other predictive equa-
tions published by Lundell and associates,4
Wessel and colleagues,5 and Lindahl6 also
do not accurately estimate VO2. All these
formulas were developed to offer a suitable
and reliable method to assume VO2 in or-
der to simplify the calculation of hemody-
namic parameters. However, these formu-
las cannot be used in all patients and
settings.
As Benallal pointed out, these formulas
include coefficients depending on charac-
teristics of the population investigated in
these studies. The difference between mea-
sured and assumed VO2 might be due to a
population difference. In addition, it is also
influenced essentially by other conditions
such as the mode of general anesthesia and
relaxation used in different institutions.
It is difficult to identify feasible coeffi-
cients to develop a formula fitting to all con-
ditions of hemodynamic evaluation during
cardiac catheterization.
Moreover, we are convinced that our
population of 143 patients is too small to
identify and validate suitable coefficients
for a new formula. LaFarge and Miettinen
derived their most commonly used formu-
las from a multivariate analysis of covari-
ance applied to data on a series of 879
patients.
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J. Hess, MD
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Linking gene expression, nuclear
factor kappa B, remote ischemic
preconditioning, and transplantation:
A quest for an elusive Holy Grail or
a road to an amazing discovery?
To the Editor:
We read with interest the recent paper of
Ishiyama and colleagues1 reporting that in-
hibition of nuclear factor kappa B (NF-B)
by IB supressor gene transfer ameliorated
ischemia-reperfusion (IR) injury after ex-
perimental lung transplantation. A few
comments seem appropriate.
Is activation of NF-B before transplan-
tation destructive or protective? Two mu-
rine studies provided seemingly contradic-
tory results. In the study of Ishiyama and
colleagues,1 inhibition of NF-B rendered
protection against the IR injury, yet in an-
other study2 a targeted deletion of the p105
subunit of the NF-B abolished the protec-
tive effect of the remote ischemic precon-
ditioning (rIPC), a novel clinically applica-
ble mode of protection against IR injury,
whereby the organs can be protected by a
brief ischemia applied remotely (eg, limb
ischemia). Gene expression appears to play
an important role in rIPC. In our own stud-
ies, the rIPC stimulus modified NF-B reg-
ulated gene expression in leukocytes3 and
the target organ,4 and when the rIPC was
applied to the recipient in porcine model it
rendered myocardial protection after the
orthotopic heart transplantation.5
It is widely known that the transcription
factor NF-B can be activated by a variety
of stimuli, for example, tumor necrosis fac-
tor (TNF)-, bacterial lipopolysaccharide
(LPS), and heat shock protein (HSP). Stim-
ulation of the cell may lead to phosphory-
lation of IB and translocation of NF-B
into the nucleus, resulting in gene expres-
sion, including those genes responsible for
exocytosis of adhesive molecules and cy-
tokine production in leukocytes, but also
for production of protective substances eg,
manganese superoxide dismutase (Mn-
SOD) and inducible nitric oxide synthase
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Letters to the Editor(iNOS)2 (Figure 1). It is perhaps less
known, however, that the “classic” NF-B
exists as a p50-p65 heteromer. The p50
derives from the precursor protein p105,
which appears to be indispensable for
rIPC.2 Suppression of gene expression of
NF-B p65 subunit by the rIPC stimulus
observed in our study3 was of special in-
terest because this might be a potential site
of uncoupling of production of cytokines
and MnSOD/iNOS synthesis (Figure 1). It
appears that the initial TNF- signaling
pathway activation by rIPC induces protec-
tive MnSOD synthesis, but yet suppresses
gene expression responsible for subsequent
cytokine production and TNF- signaling
pathway restoration. Taking into consider-
ation that general nonspecific inhibition of
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508 The Journal of Thoracic and Cardiovaprotection of ischemic preconditioning, it
seems likely that a brief activation of
NF-B might be protective, while its sus-
tained activation may have detrimental re-
sults. Or, perhaps, a unit-specific activation
of the NF-B is more important?
Further research of NF-B involvement
in IR injury, particularly in transplantation,
could be an area where the major discov-
eries in cardiothoracic surgery may be
made.
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555 University Ave
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From mesothelioma to
cardiovascular protection via the
phosphoinositide-3 kinase pathway:
A new vista in cardiothoracic
surgery
To the Editor:
We read with interest the article by Rascoe
and colleagues1 on the role of tyrosine kinase
receptors and the phosphoinositide-3 kinase
(PI3K) pathway in mesothelioma. The au-
thors demonstrated differential involvement
of 3 growth factor (GF) receptors—epider-
mal growth factor (EGF), insulin-like growth
factor (IGF), and platelet-derived growth fac-
tor (PDGF) receptors—in PI3K-mediated
survival of the malignant mesothelioma cells.TSurvival of many cells under stress, par-
ticularly of myocytes, is dependent on PI3K
pathway activation.2 It is not often appreci-
ated, however, that the PI3K pathway can
be activated not only via tyrosine kinase
receptors by GFs, but also via toll-like re-
ceptor by heat shock protein, bacterial li-
popolysaccharide, and by tumor necrosis
factor (Figure 1). Although the precise
molecular mechanisms by which the GF
receptors interact with PI3K pathway are
unknown, they appear to have different
properties. For example, PDGF appears to
play a crucial role in the pathogenesis of
atherosclerosis.3 We agree with Rascoe
and colleagues that PDGF receptor inhibi-
tion does not negatively affect cellular sur-
vival. In fact, PDGF inhibition results in
significant reduction in oxidative stress3
and is observed after ischemic precondi-
tioning.4 Indeed, we have previously dem-
onstrated that intravenous infusion of IGF
improves oxygen transport by reducing ox-
ygen consumption as well as increasing
cardiac output and oxygen delivery after
ischemia-reperfusion (IR) injury.5 Further-ar
he Journal of Thoracic and Cardiovascularmore, cardiovascular protection from IR
injury is abrogated when PI3K pathway is
inhibited by LY294002.2 Thus, systemic
inhibition of IGF or PI3K may result in
detrimental clinical side effects.
While local inhibition of PI3K signaling
either directly or via EGF receptor inhibition
may appear a promising treatment for me-
sothelioma, it is possible that sustained sys-
temic inhibition of PI3K, either directly by
LY294002 or indirectly via tyrosine kinase
receptor inhibition, could lead to rapid pro-
gression of vascular disease and increased
myocardial vulnerability to IR syndromes
in susceptible patients. Whatever the clin-
ical implications of the study by Rascoe
and colleagues might be, any therapeutic
intervention must be applied cautiously and
balanced carefully against potential risks.
In summary, we congratulate Rascoe and
colleagues on their stimulating and thought-
provoking study. It is clear that contemporary
academic cardiothoracic surgery must be per-
formed within the realms of an understand-
ing of the burgeoning field of molecular
gure 1. Schematic of phosphoinositide-3
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